NEUMÜNSTER, Germany, July 19, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a number one world cannabis-lifestyle and shopper packaged items firm inspiring and empowering the worldwide group to dwell their easiest life, immediately introduced that its medical hashish division, Tilray Medical, launched a brand new hashish schooling platform, WeCare-MedicalCannabis, devoted to offering assets and educating healthcare practitioners and sufferers about medical hashish.
WeCare-MedicalCannabis supplies science and research-based hashish content material tailor-made to healthcare professionals, caregivers, and sufferers to assist them make knowledgeable selections about medicinal hashish and assists them alongside their path to discovering how medicinal hashish can help each day wellness and well being. Designed to function a one-stop, complete useful resource on medical hashish insights, WeCare-MedicalCannabis is now out there in Germany, France, the United Kingdom, and Portugal.
Sascha Mielcarek, Managing Director, Tilray Europe, mentioned, “As global pioneers in medical cannabis, we are aware of the lack of access to science-based, medical cannabis education. WeCare-MedicalCannabis was created to bridge that gap and help provide the needed resources to helping patients, caregivers, and healthcare professionals with the information they need to make informed decisions on medicinal cannabis. As cannabis legalization continues to expand across Europe, Tilray Medical is dedicated to help provide informed and trusted guidance for those interested in learning more about medical cannabis.”
Tilray Medical continues to work with main affected person associations and doctor societies, offering worth to these impacted by adjustments inside the medical panorama, and who serve on the forefront of world well being initiatives. By offering entry to instructional platforms reminiscent of WeCare-MedicalCannabis, Tilray Medical continues to open and increase its world of wellbeing.
For extra data, please go to our world platforms at WeCare-MedicalCannabis Germany, WeCare-MedicalCannabis France, WeCare-MedicalCannabis UK, WeCare-MedicalCannabis Portugal.
About Tilray Medical
Tilray Medical is devoted to bettering the standard of life for sufferers around the globe, remodeling lives, and fostering dignity for sufferers in want by protected and dependable entry to a worldwide portfolio of medicinal hashish manufacturers. Tilray grew from being one of many first corporations to turn into an accredited licensed producer of medicinal hashish in Canada to constructing the primary GMP-certified hashish manufacturing services in Europe, first in Portugal and later in Germany. Today, Tilray Medical is likely one of the greatest suppliers of medicinal hashish manufacturers to sufferers, physicians, hospitals, pharmacies, researchers, and governments, in 20 international locations and throughout 5 continents.
For extra data on Tilray Medical, go to Tilray Medical Canada, Tilray Medical Australia-New Zealand, Tilray Medical Europe
About Tilray Brands, Inc.
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a number one world cannabis-lifestyle and shopper packaged items firm with operations in Canada, the United States, Europe, Australia, and Latin America that’s altering folks’s lives for the higher – one individual at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide group to dwell their easiest life and by offering entry to merchandise that meet the wants of their thoughts, physique, and soul whereas invoking wellbeing. Patients and shoppers belief Tilray Brands to ship a cultivated expertise and well being and wellbeing by high-quality, differentiated manufacturers and progressive merchandise. A pioneer in hashish analysis, cultivation, and distribution, Tilray’s unprecedented manufacturing platform helps over 20 manufacturers in over 20 international locations, together with complete hashish choices, hemp-based meals, and craft drinks.
For extra data on how we open a world of wellbeing, go to www.tilray.com and comply with @tilray.
Forward-Looking Statements
Certain statements on this communication that aren’t historic info represent forward-looking data or forward-looking statements (collectively, “forward-looking statements”) underneath Canadian securities legal guidelines and inside the which means of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which can be meant to be topic to the “safe harbor” created by these sections and different relevant legal guidelines. Forward-looking statements might be recognized by phrases reminiscent of “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the detrimental of those phrases or comparable expressions, though not all forward-looking statements comprise these figuring out phrases. Certain materials components, estimates, objectives, projections, or assumptions had been utilized in drawing the conclusions contained within the forward-looking statements all through this communication. Forward-looking statements embrace statements relating to our intentions, beliefs, projections, outlook, analyses, or present expectations regarding, amongst different issues: expectations relating to the efficiency and scale of the Company, together with Tilray Medical; and the Company’s capability to increase its providing to sufferers worldwide, together with through Tilray Medical. Many components might trigger precise outcomes, efficiency, or achievement to be materially totally different from any forward-looking statements, and different dangers and uncertainties not presently recognized to the Company or that the Company deems immaterial might additionally trigger precise outcomes or occasions to vary materially from these expressed within the forward-looking statements contained herein. For a extra detailed dialogue of those dangers and different components, see probably the most just lately filed annual data type of Tilray and the Annual Report on Form 10-Ok (and different periodic reviews filed with the SEC) of Tilray made with the SEC and out there on EDGAR. The forward-looking statements included on this communication are made as of the date of this communication and the Company doesn’t undertake any obligation to publicly replace such forward-looking statements to replicate new data, subsequent occasions, or in any other case except required by relevant securities legal guidelines.
For additional data:
Media
Berrin Noorata
information@tilray.com
Investors
Raphael Gross
Raphael.Gross@icrinc.com
